Test Price
550 AED✅ Home Collection Available
Peripheral Blood Karyotyping (Single) Test in UAE | 550 AED | DHA Licensed
Executive Summary & Core Metrics
Executive Summary & Core Metrics
- Diagnostic Accuracy: 99.9% sensitivity for aneuploidies and major structural defects via ISO 9001:2015 certified G‑banding analysis.
- VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection: Available daily from 8 AM to 11 PM.
- Post‑test teleconsultation with a Consultant Medical Genetics to interpret results in clinical context.
- Insurance coverage verification via WhatsApp at +971545488731.
Test Overview & Methodology
Peripheral blood karyotyping is a genetic test that examines all 46 chromosomes for numerical and structural abnormalities. It is essential for diagnosing chromosomal disorders, recurrent miscarriages, and hematologic malignancies. The analysis is performed on cultured white blood cells using G‑banding, providing a comprehensive view of the entire chromosome complement.
| Feature | Our Test (Peripheral Blood Karyotyping – Single) | Closest Alternative (Chromosomal Microarray / FISH) |
|---|---|---|
| Methodology | Conventional Karyotyping (G‑banding) via Cell Culture – ISO 9001:2015 certified | Microarray (CMA) or targeted FISH; may not detect balanced rearrangements |
| Diagnostic Precision | 99.9% sensitivity for aneuploidies & major structural defects | High‑resolution CNV detection but cannot visualise all balanced translocations |
| Turnaround Time | 7–9 days (cultured cell analysis) | 3–5 days for targeted FISH; CMA may take 5–10 days |
| Regulatory Compliance | Full DHA/MOHAP alignment, UAE PDPL & Federal Law No. 2 of 2019 on ICT in Health | Variable; often lacks local ISO accreditation |
Physician Insight & Safety Protocols
“Peripheral blood karyotyping remains the gold standard for detecting balanced chromosomal rearrangements and aneuploidies that underlie many genetic disorders and recurrent pregnancy losses. Our laboratory adheres to rigorous cell culture and G‑banding protocols to ensure results you can trust. I emphasise that every karyotype finding must be reviewed alongside the patient’s full clinical and family history for accurate interpretation.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration ID: 9294403)
Medication Advisory
Always inform your referring physician about all prescription medications, over‑the‑counter drugs, and supplements you are currently taking before blood collection. Most medications do not interfere with cell culture or chromosome analysis, but certain chemotherapeutic agents may affect cell growth. Do not stop or adjust any prescribed medication without direct consultation with your doctor.
Exclusion Criteria & Emergency Red Flags
- Active systemic infection with fever >38°C – reschedule after full recovery.
- Severe anaemia (Hb <7 g/dL) – physician clearance required prior to draw.
- Blood transfusion within the past 2 weeks – may compromise cell culture success.
- High bleeding risk due to anticoagulant therapy – consult your doctor before proceeding.
- If you experience fainting, severe pain, or signs of infection (redness, swelling, pus) at the venipuncture site after collection, seek emergency medical attention immediately.
Patient FAQ & Clinical Guidance
1. What is peripheral blood karyotyping and why is it performed?
Peripheral blood karyotyping analyses the number and structure of all 46 chromosomes from a blood sample. It is ordered by gynaecologists, haematologists, and clinical geneticists to investigate recurrent pregnancy loss, suspected chromosomal syndromes (e.g., Down, Turner, Klinefelter), and haematologic malignancies such as leukaemia. The test provides a complete microscopic view of the chromosome complement, detecting large deletions, duplications, and balanced translocations that other methods may miss.
2. How is the test conducted and when will I receive my results?
A small volume (2 mL) of peripheral blood is collected into a sodium heparin vacutainer and transported under temperature‑controlled cold‑chain conditions to our ISO‑accredited laboratory. White blood cells are cultured, arrested in metaphase, and stained using G‑banding for chromosome counting and structural analysis. Standard results are available within 7–9 days from sample receipt. The final report is reviewed by a certified cytogeneticist and delivered securely through our digital portal.
3. Does the test cause pain and are there any associated risks?
The procedure is a routine venipuncture identical to a standard blood draw. Most patients experience only a brief pinch. Our experienced phlebotomists use sterile, single‑use equipment to minimise any risk. Minor bruising at the puncture site is the most common side effect; serious complications are extremely rare when the draw is performed by trained professionals following established safety protocols.
UAE Regulatory & Data Privacy Adherence
Your Data, Your Rights – Fully Compliant with UAE Federal Law
- Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL): All personal and genetic data is processed lawfully, with explicit consent, and stored securely within UAE‑based infrastructure.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields: Digital health records, teleconsultation, and electronic reporting adhere to the highest standards of confidentiality and integrity.
- Federal Decree‑Law No. 4 of 2016 on Medical Liability: Clinical testing, patient consent, and safety protocols comply with national medical liability regulations, ensuring accountability and patient protection.
- ISO 9001:2015 Certified (Cert. INT/EGQ/2509DA/3139) – Quality management systems audited annually.
Clinical & Logistical Metadata
| Test Name | Peripheral Blood Karyotyping (Single) |
| Price (AED) | 550 AED |
| Turnaround Time | 7–9 business days from sample receipt |
| Sample Type / Matrix | Peripheral whole blood (2 mL in sodium heparin vacutainer). VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection available daily from 8 AM to 11 PM. |
| Methodology Used | Conventional Karyotyping (G‑banding) via Cell Culture – ISO 9001:2015 certified |
| ICD‑10‑CM Code | Z01.5 |
| LOINC Code | 22400-9 |
| DHA Facility License & Address | DHA Facility License No. 1143 · Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE · Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians